机构：[1]Department of Otorhinolaryngology, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands[2]Department of ORL-HNS, Université de Montréal, Montreal, Canada[3]Rhinology and Skull Base Department, Applied Medical Research Centre, UNSW (Conjoint) and Macquarie University (Clinical), Sydney, Australia[4]Ear, Nose and Throat Department, Guys and St. Thomas' Hospital, London, United Kingdom[5]Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain[6]Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, UK[7]ENT Department, James Paget University Hospital, Great Yarmouth, UK[8]Rhinology and Skull Base Unit, ENT Department, Hospital Clínic de Barcelona, Universidad de Barcelona, August Pi i Sunyer Biomedical ResearchInstitute, Barcelona, Spain[9]Division of Otorhinolaryngology, Department of Ophthalmology, Otorhinolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School-University of Sao Paulo, Sao Paulo, Brazil[10]Upper Airways Research Laboratory and ENT Department, University Hospital Ghent, Ghent, Belgium[11]Division of ENT Diseases, CLINTEC, Karolinska Institute, University of Stockholm, Stockholm, Sweden[12]Department of Otolaryngology-Head and Neck Surgery, The University of Chicago Medicine and the Comer Children's Hospital, Chicago, IL, USA[13]ENT Department Hospital Quironsalud, University of Valencia, Valencia, Spain[14]Department of Otolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University, Hospital, Copenhagen, Denmark[15]Department of Otolaryngology, Head and Neck Surgery, Royal Brisbane and Women’s Hospital.Faculty of Medicine, University of Queensland,Brisbane, Australia[16]Department of Otorhinolaryngology - Head and Neck Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA,USA[17]1st Department of ORL, Head and Neck Surgery, Aristotle University, AHEPA Hospital, Thessaloniki, Greece[18]Rhinology and Plastic Surgery Unit, Otorhinolaryngology, Head and Neck Surgery and Pediatric ENT Department, CHU de Bordeaux, HôpitalPellegrin, Centre F-X Michelet, Bordeaux, France[19]Department of Surgery, The University of Auckland, Auckland, New Zealand[20]Department of Otorhinolaryngology, Ghent University, Ghent, Belgium[21]University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb, Croatia[22]Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium[23]Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium[24]ENT Department, Zagreb School of Medicine, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia[25]Department of Otolaryngology - Head and Neck Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA[26]Patient representative, Opuscomms, London, UK[27]Department of Inhalation Medicine, Observational Pragmatic Research Institute, Singapore[28]Rhinology-Olfactology Unit, Otorhinolaryngology Department, University Hospital of Geneva, Geneva, Switzerland[29]Medical Information Specialist, Medical Library, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands[30]Department of Bioscience Engineering, University of Antwerp, Antwerp, Belgium[31]FCS – UBI Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal[32]Department of Pediatric Pneumology and Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany[33]Department of Otorhinolaryngology, Head and Neck Surgery, Ankara University, Ankara, Turkey[34]Department of Otorhinolaryngology, Head and Neck Surgery, Salzburg Paracelsus Medical University, Salzburg, Austria[35]Departments of Medicine and Microbiology, APC Microbiome Ireland, National University of Ireland, Cork, Ireland[36]Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK[37]Optimum Patient Care, Cambridgeshire, UK[38]Department of Otolaryngology – Head and Neck Surgery, Medical University of South Carolina, Charleston, USA[39]UNC Otolaryngology / Head and Neck Surgery, Division of Rhinology, Allergy, and Endoscopic Skull Base Surgery and Department of Neurosurgery,University of North Carolina School of Medicine, Chapel Hill, NC, USA[40]Patient representative, Task Force Healthcare, WTC Den Haag, The Netherlands[41]Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Graz, Graz, Austria[42]Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland[43]Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore[44]Rhinology Division, ENT Department Eye and ENT Hospital, Fudan University, Shanghai, China[45]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Beijing, China临床科室耳鼻咽喉-头颈外科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[46]Royal National Throat, Nose and Ear Hospital, UCLH, London, UK
Background: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common condition with high impact on quality of life is managed around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clear recommendations based on all available evidence. Methodology: Based on the AGREE II framework, this article demonstrates how the EPOS2020 steering group will address six key areas to ensure consistency in quality and presentation of information in the latest rhinosinusitis clinical practice guideline: scope and purpose; stakeholder involvement; rigour of development; clarity of presentation; recommendations and applicability; editorial independence. Results: By analysing the guidance from AGREE II, we formulated a detailed development strategy for EPOS2020. We identify new stakeholders and target users and ratify the importance of patient involvement in the latest EPOS guideline. New and expanded areas of research to be addressed are highlighted. We confirm our intention to use mixed methodologies, combining evidencebased medicine with real life studies; when no evidence can be found, use Delphi rounds to achieve clear, inclusive recommendations. We also introduce new concepts for dissemination of the guideline, using Internet and social media to improve accessibility. Conclusion: This article is an introduction to the EPOS2020 project, and presents the key goals, core stakeholders, planned methodology and dissemination strategies for the latest version of this influential guideline.
第一作者机构：[1]Department of Otorhinolaryngology, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands[*1]Department of Otorhinolaryngology Room A2-230 Amsterdam University Medical Centres Location AMC 1105 AZ Amsterdam The Netherlands
通讯作者：
通讯机构：[1]Department of Otorhinolaryngology, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands[*1]Department of Otorhinolaryngology Room A2-230 Amsterdam University Medical Centres Location AMC 1105 AZ Amsterdam The Netherlands
推荐引用方式(GB/T 7714)：
Wytske Fokkens,Martin Desrosiers,Richard Harvey,et al.EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis[J].RHINOLOGY.2019,57(3):162-168.doi:10.4193/Rhin19.080.
APA：
Wytske Fokkens,Martin Desrosiers,Richard Harvey,Claire Hopkins,Joaquim Mullol...&Valerie Lund.(2019).EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis.RHINOLOGY,57,(3)
MLA：
Wytske Fokkens,et al."EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis".RHINOLOGY 57..3(2019):162-168
